| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $212K | -34.6% |
| Cost of Revenue | $0 | — |
| Gross Profit | $212K | -34.6% |
| R&D Expense | $74.6M | +8.4% |
| SG&A Expense | $22.2M | -9.7% |
| Operating Income | -$96.6M | -3.8% |
| Pre-tax Income | -$88.4M | -7.7% |
| Income Tax | $0 | — |
| Net Income | -$88.4M | -7.7% |
| EPS (Basic) | -$0.99 | -6.5% |
| EPS (Diluted) | -$0.99 | -6.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $57K | +1325.0% |
| Current Assets | $136.0M | -28.1% |
| Total Assets | $146.0M | -31.4% |
| Current Liabilities | $23.9M | +29.4% |
| Total Liabilities | $24.3M | +23.2% |
| Stockholders' Equity | $121.7M | -37.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$75.0M | -8.5% |
| Capital Expenditures | $287K | +222.5% |
| Investing Cash Flow | $71.3M | +1.0% |
| Financing Cash Flow | $7.0M | +2188.6% |
| Free Cash Flow | -$75.3M | -8.8% |